Financial Network Wealth Advisors LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2012031
MURRAY, UT
Position in REGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$41,153
-$9,841 QoQ
Shares Held
66
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,109
of 1,297 holders
Holding Since
Jun 2024
9 quarters on record
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financial Network Wealth Advisors LLC holds $234,517 across 15 Biotechnology names. REGN ranks #3 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182 | $90,404 | |
| 2 | TECH |
BIO-TECHNE Corp
|
607 | $42,884 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
66 | $41,153 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
2,638 | $25,905 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
200 | $6,864 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
20 | $6,321 | |
| 7 | MRNA |
Moderna, Inc.
|
86 | $6,022 | |
| 8 | IMNM |
Immunome Inc.
|
179 | $3,793 |
All Filings in REGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,153 | 66 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $50,994 | 66 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $24,699 | 32 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,305 | 29 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $9,450 | 18 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,610 | 12 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,698 | 8 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,666 | 13 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $9,459 | 9 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||